Medicare Enrolled
Dr. Daniel Lamont, M.D.
Cardiovascular Disease · Laguna Hills, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lamont from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lamont?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lamont
Dr. Daniel Lamont is a cardiovascular disease specialist in Laguna Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lamont performed 5,935 Medicare services across 3,493 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lamont received a total of $24,295 from 57 pharmaceutical and/or device companies across 932 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lamont is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$24,295 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,935
Medicare services
Top 15% in CA for cardiovascular disease
3,493
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~312 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
932 | $12 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
904 | $103 | $151 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
842 | $21 | $39 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
379 | $161 | $248 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
306 | $25 | $40 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
244 | $7 | $55 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
218 | $22 | $44 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $72 | $110 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
159 | $100 | $130 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
151 | $146 | $231 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
135 | $136 | $192 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
130 | $41 | $88 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
130 | $20 | $61 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
130 | $210 | $338 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
118 | $46 | $71 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
114 | $21 | $40 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
114 | $795 | $1,100 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
112 | $44 | $65 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
107 | $41 | $60 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
67 | $30 | $51 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
64 | $68 | $100 |
| Cardiac catheterization | 59 | $184 | $425 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
56 | $102 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
52 | $67 | $95 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
33 | $432 | $677 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
31 | $175 | $280 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $110 | $150 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
29 | $62 | $121 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
28 | $410 | $596 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
27 | $90 | $140 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
24 | $52 | $70 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
14 | $77 | $120 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
12 | $13 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.9% high complexity
9.4% medium
72.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,295
Total received (2018-2024)
Avg $3,471/year across 7 years
Top 15% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
932
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,159 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$137 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,857
2023
$3,698
2022
$3,712
2021
$2,599
2020
$2,360
2019
$5,608
2018
$3,460
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$335
BIOTRONIK INC.
$263
Boston Scientific Corporation
$260
Inari Medical, Inc.
$220
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$200
Amgen Inc.
$188
Alnylam Pharmaceuticals Inc.
$170
SCPHARMACEUTICALS INC.
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$147
Janssen Pharmaceuticals, Inc
$130
E.R. Squibb & Sons, L.L.C.
$102
Abbott Laboratories
$92
PFIZER INC.
$90
Merck Sharp & Dohme LLC
$73
Actelion Pharmaceuticals US, Inc.
$65
Kiniksa Pharmaceuticals International, plc
$61
CARDIVA MEDICAL, INC.
$55
Medtronic, Inc.
$51
Kestra Medical Technology Services, Inc.
$49
SANOFI-AVENTIS U.S. LLC
$47
Bayer Healthcare Pharmaceuticals Inc.
$45
Novo Nordisk Inc
$24
Esperion Therapeutics, Inc.
$23
Philips North America LLC
$14
Top 3 companies account for 30.0% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$2,621
Amgen Inc.
$2,268
Boston Scientific Corporation
$1,722
Novartis Pharmaceuticals Corporation
$1,506
Penumbra, Inc.
$1,277
Abbott Laboratories
$1,070
SANOFI-AVENTIS U.S. LLC
$921
PFIZER INC.
$908
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$870
Janssen Pharmaceuticals, Inc
$829
Inari Medical, Inc.
$719
Regeneron Healthcare Solutions, Inc.
$717
Impulse Dynamics (USA) Inc.
$699
Medtronic Vascular, Inc.
$672
Boehringer Ingelheim Pharmaceuticals, Inc.
$617
E.R. Squibb & Sons, L.L.C.
$579
Alnylam Pharmaceuticals Inc.
$485
ABIOMED
$415
Esperion Therapeutics, Inc.
$348
Chiesi USA, Inc.
$326
ShockWave Medical, Inc
$311
SCPHARMACEUTICALS INC.
$307
Shockwave Medical, Inc
$294
Novo Nordisk Inc
$279
CVRx, Inc.
$276
Medtronic, Inc.
$243
Astellas Pharma US Inc
$237
Merck Sharp & Dohme LLC
$217
Amarin Pharma Inc.
$216
Gilead Sciences, Inc.
$205
Edwards Lifesciences Corporation
$202
Otsuka America Pharmaceutical, Inc.
$198
BOSTON SCIENTIFIC CORPORATION
$194
Kestra Medical Technology Services, Inc.
$180
Bayer Healthcare Pharmaceuticals Inc.
$160
AstraZeneca Pharmaceuticals LP
$158
Kiniksa Pharmaceuticals, Ltd.
$109
Merck Sharp & Dohme Corporation
$101
Tactile Systems Technology Inc
$101
Cardiovascular Systems Inc.
$95
CHIESI USA, INC.
$77
Arbor Pharmaceuticals, Inc.
$68
Actelion Pharmaceuticals US, Inc.
$65
Kiniksa Pharmaceuticals International, plc
$61
CARDIVA MEDICAL, INC.
$55
Allergan Inc.
$50
Cardinal Health 200, LLC
$48
Azurity Pharmaceuticals, Inc.
$41
Bardy Diagnostics, Inc.
$37
Preventice Services, LLC
$32
Celgene Corporation
$24
AtriCure, Inc.
$19
Philips North America LLC
$14
Lundbeck LLC
$14
ARALEZ PHARMACEUTICALS US INC.
$14
Itamar Medical Inc
$14
ATRICURE, INC.
$13
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
(BS2) LM Undivided · AMPLATZER AMULET · AMVIA EDGE · AMVUTTRA · Acticor · Acticor 7 VR-T DX · Advisa · Arcalyst · Arctic Front · Asahi Fielder coronary guide wire · Assure WCD · Azure · BG Mini Plus · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Carnation Ambulatory Monitor · Cobalt · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · Diamondback Coronary · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FORTIFY ASSURA · FUROSCIX · Flexitouch Plus · GENERAL TACHY · GENERAL BRADY · GENERAL TACHY · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL TACHY · GENERAL THERAPIES · HeartWare HVAD · Impella · Indigo · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LATITUDE · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · OPTIS · OPTOWIRE · Optimizer · Orsiro · Orsiro Mission · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESSUREWIRE · Pacemakers · Penumbra System · Peripheral Orbital Atherectomy System · RELIANCE 4 FRONT · RESONATE · Repatha · Resolute · Reveal LINQ · S · SAMSCA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Solia · Tryton Side Branch Stent · VENASEAL · VERQUVO · VIGILANT X4 CRT-D · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WatchPAT · Wegovy · XARELTO · XIENCE SKYPOINT · Xience Alpine cornary stent system · Xience Sierra Coronary Stent System · ZONTIVITY · ZOOM Wireless Transmitter · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
192
Per 100K population
6.1
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lamont is a remote & electrophysiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lamont experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Lamont performed 932 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lamont receive payments from pharmaceutical companies?
Yes. Dr. Lamont received a total of $24,295 from 57 companies across 932 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lamont's costs compare to other cardiologists in Laguna Hills?
Dr. Lamont's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lamont) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Laguna Hills
Browse cardiologists in Laguna Hills ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology